Medical prevention of occupational risks of infection Marie-Ccile - - PowerPoint PPT Presentation

▶
medical prevention of occupational risks of infection
SMART_READER_LITE
LIVE PREVIEW

Medical prevention of occupational risks of infection Marie-Ccile - - PowerPoint PPT Presentation

Oct 14, 2022 50 likes •242 views

EFICATT Medical prevention of occupational risks of infection Marie-Ccile BAYEUX-DUNGLAS Medical Advisor INRS Paris- FRANCE Dsseldorf 21.10.2011 www.issa.int Accidental exposure to infectious agents in the workplace Infectious risk

slide-1
SLIDE 1

www.issa.int

EFICATT

Medical prevention of occupational risks of infection

Marie-Cécile BAYEUX-DUNGLAS Medical Advisor INRS Paris- FRANCE Düsseldorf 21.10.2011

slide-2
SLIDE 2

www.issa.int

Infectious risk following accidental exposure to biological agents in the workplace has rarely been studied (apart from a few specific risks) Specific importance of post exposure measures Elaboration of a guide on the actions to be taken

Accidental exposure to infectious agents in the workplace

Düsseldorf 21.10.2011

2

slide-3
SLIDE 3

www.issa.int

EFICATT: Background

2001: Agreement between

The French Research and Safety Institute for the Prevention of Occupational Accidents and Diseases (INRS) and the study group on healthcare workers’ exposure to infectious risks (GERES)

Aim: to build a concise reference tool with consensus-based recommendations for actions to be taken 2004: Setting up of the working group

Editorial Committee Scientific Committee

Düsseldorf 21.10.2011

3

slide-4
SLIDE 4

www.issa.int

INRS in brief

Articles of association

A non-profit organisation A joint Board of Directors with staff and management equally represented An independent Scientific Committee

Purpose: to develop occupational risk prevention

Preserving health and safety at work, developing prevention solutions for the benefit of all the players in the working world

Funding

National Fund for the Prevention of Occupational Accidents and Diseases of the CNAM-TS, financed by company contributions

Düsseldorf 21.10.2011

4

slide-5
SLIDE 5

www.issa.int

GERES in brief

A non-profit university-based research group for the prevention of occupational infections among health care workers (HCWs) founded in 1991

GERES - Faculté Médecine BICHAT 16 rue Henri Huchard, 75018 Paris, France. Tél : (33) 1 57 27 78 70 - Fax : (33) 1 57 27 77 01 e-mail: geres@geres.org – web site: www.geres.org

Düsseldorf 21.10.2011

5

slide-6
SLIDE 6

www.issa.int

EFICATT: Editorial Committee

Role of the Editorial Committee: Schedule the drafting of data sheets by order of priority Select authors in agreement with the Scientific Committee Follow up the data sheet drafting with the authors Harmonise contributions to ensure consistency

INRS GERES Geneviève ABADIA Marie-Cécile BAYEUX-DUNGLAS Elisabeth BOUVET Dominique ABITEBOUL

Düsseldorf 21.10.2011

6

slide-7
SLIDE 7

www.issa.int

EFICATT: Scientific Committee

Comprising physicians specialised in different fields

Infectious diseases, Occupational medicine, Hospital hygiene, Bacteriology, Virology…

Roles of the Scientific Committee

Assist the Editorial Committee in the scientific approach Validate the data sheets submitted by the authors

Düsseldorf 21.10.2011

7

slide-8
SLIDE 8

www.issa.int

EFICATT: aim

Concise reference tool targeted at all physicians Bringing together scientific elements and valuable

  • fficial recommendations

Support for risk assessment Serves to define

the immediate action to be taken subsequent actions to be taken medical follow-up to be implemented

Düsseldorf 21.10.2011

8

slide-9
SLIDE 9

www.issa.int

The EFICATT guide

Online database Data sheets divided into 4 sections: Pathogen and pathology Procedure to follow in the event of exposure The specific case of laboratory exposure References 2006: Publication of the first data sheet

Düsseldorf 21.10.2011

9

slide-10
SLIDE 10

www.issa.int

EFICATT Guide

www.inrs.fr/eficatt

Düsseldorf 21.10.2011

10

slide-11
SLIDE 11

www.issa.int

Data sheet reading guide

11

Düsseldorf 21.10.2011

11

slide-12
SLIDE 12

www.issa.int

Düsseldorf 21.10.2011

12

slide-13
SLIDE 13

www.issa.int

Düsseldorf 21.10.2011

13

slide-14
SLIDE 14

www.issa.int

Pathogen and pathology

Reservoir Infectivity Epidemiological data Transmission, incubation, clinical signs, diagnosis, treatment Vaccine prevention Populations at risk Pregnancy

Düsseldorf 21.10.2011

14

slide-15
SLIDE 15

www.issa.int

Procedure to follow in the event

  • f exposure

Definition of who must be considered as exposed Risk assessment Immediate action to be taken Prophylactic measures Medical follow-up Reference texts

Düsseldorf 21.10.2011

15

slide-16
SLIDE 16

www.issa.int

The specific case of laboratory exposure

Published cases Particularity of the risk assessment Effect on the action to be taken

Düsseldorf 21.10.2011

16

slide-17
SLIDE 17

www.issa.int

EFICATT: References

Direct links to regulatory reference documents

Düsseldorf 21.10.2011

17

slide-18
SLIDE 18

www.issa.int

EFICATT prospects

Regular data sheet updates New sheets to be added: Adenovirus conjunctivitis Pediculosis Chikungunya, etc.

Düsseldorf 21.10.2011

18

slide-19
SLIDE 19

www.issa.int

EFICATT Guide: conclusion

Online at www.inrs.fr/eficatt 33 sheets currently available (in French only)

Thank you for your attention

Düsseldorf 21.10.2011

19